Simplify Propel Opportunities ETF
Not enough financial coverage to compute a composite score for SURI. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.simplify.us/etfs/suri-simplify-propel-opportunities-etf
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.
- IPO
- 2023
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $74.27M
- Div Yield
- 15.71%
Performance & Tape
- 52W High
- $18.50
- 52W Low
- $14.27
- 50D MA
- $16.89
- 200D MA
- $16.64
- Beta
- 1.21
- Avg Volume
- 11.49K
Get TickerSpark's AI analysis on SURI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SURI Coverage
We haven't published any research on SURI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SURI Report →